Mrs. Alisha Lee Ettleman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1314 3rd Ave, Nebraska City, NE 68410 Phone: 402-873-8918 |
Kayla Renae Crisler, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1420 N 10th St, Nebraska City, NE 68410 Phone: 402-873-3304 |
Mrs. Crystal Lee Bennett, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1240 N 19th St, Nebraska City, NE 68410 Phone: 402-873-4838 |
Abby Lollmann, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 136 Arbor View Dr, Nebraska City, NE 68410 Phone: 402-873-2899 |
Mr. Steven Bowen Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1420 N 10th St, Nebraska City, NE 68410 Phone: 402-873-3304 |
Mrs. Abby Hanson Mathis, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1800 14th Ave, Nebraska City, NE 68410 Phone: 402-873-6650 |
Mrs. Chellona Vermaas, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1251 N 14th St, Nebraska City, NE 68410 Phone: 402-890-4905 |
Nebraska City Care And Rehabilitation Center, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1420 N 10th St, Nebraska City, NE 68410 Phone: 402-873-3304 Fax: 402-873-6307 |
News Archive
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer.
Children suffering from Attention Deficit Hyperactivity Disorder (ADHD) may be ignoring visual information to their left and being diagnosed mistakenly as having dyslexia, according to new research by Dr Tom Manly and colleagues at the Medical Research Council (MRC) Cognition and Brain Sciences Unit in Cambridge and published in Journal of Child Psychology and Psychiatry and Brain and Cognition.
Novavax, Inc., the American vaccine development company, has been developing a recombinant protein nanoparticle COVID-19 vaccine currently termed NVX-CoV2373. The full-length spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is created in a baculovirus vector, which is then inserted into a lipid nanoparticle around 50 nm in diameter.
Hospitals in San Francisco vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.
› Verified 7 days ago